# Tumor-associated long non-coding RNAs show variable expression across diffuse gliomas and effect on cell growth upon silencing in glioblastoma

**Authors:** Joonas Uusi-Mäkelä, Maria Kauppinen, Janne Seppälä, Serafiina Jaatinen, Birgitta Ryback, Tommi Rantapero, Alejandra Rodriguez-Martinez, Matti Nykter, Kirsi J. Rautajoki

PMC · DOI: 10.1038/s41598-025-99984-9 · Scientific Reports · 2025-05-09

## TL;DR

This study identifies 22 lncRNAs linked to gliomas, showing they are overexpressed in tumors and affect cancer cell growth when silenced.

## Contribution

The study discovers 22 novel lncRNAs associated with glioma progression and survival, with functional validation in glioblastoma cell lines.

## Key findings

- 22 lncRNAs were upregulated in diffuse gliomas compared to normal brain tissue.
- Silencing three lncRNAs reduced GBM cell growth and colony formation.
- 14 of the lncRNAs were associated with patient survival in diffuse gliomas.

## Abstract

Long noncoding RNAs (lncRNAs) have been recently recognized as critical components of cancer biology linked to oncogenic processes. Certain lncRNAs are known to act as oncogenes, and the disease-specific expression of many lncRNAs makes them informative biomarkers. We identified 22 uncharacterized lncRNAs from RNA-seq data of 169 glioblastoma (GBM) tumor samples sequenced by The Cancer Genome Atlas (TCGA) consortium and studied their expression in TCGA diffuse glioma cohort including also IDH-mutant astrocytomas and oligodendrogliomas as well as in normal brain samples from the Genotype-Tissue Expression cohort. All of the 22 lncRNAs were clearly upregulated in diffuse gliomas samples compared to the normal brain. Interestingly, 20 (91%) of these lncRNAs had significant expression differences between tumor grades and/or entities, and 14 (64%) were associated with overall patient survival. All 22 lncRNAs were expressed in at least one of the studied GBM cell lines and 10 (45%) were expressed in all four. When six of the lncRNAs were silenced in the SNB19 GBM cell line, the knock-down was associated with reduced growth and colony formation for three lncRNAs: TCONS_l2_00001282, lnc-GBMT-6, and lnc-NBN-1. In conclusion, the studied lncRNAs are associated with survival in patients with diffuse glioma and have functional relevance in GBM.

## Linked entities

- **Diseases:** glioblastoma (MONDO:0018177), oligodendroglioma (MONDO:0002540)

## Full-text entities

- **Genes:** IDH1 (isocitrate dehydrogenase (NADP(+)) 1) [NCBI Gene 3417] {aka HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC}, DHCR7-DT (DHCR7 divergent transcript) [NCBI Gene 129810502] {aka AP, lnc}
- **Diseases:** oligodendrogliomas (MESH:D009837), diffuse glioma (MESH:D005910), GBM (MESH:D005909), Cancer (MESH:D009369), astrocytomas (MESH:D001254), oncogenes (MESH:D000074723)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** SNB19 — Homo sapiens (Human), Astrocytoma, Cancer cell line (CVCL_0535)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12064817/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12064817/full.md

---
Source: https://tomesphere.com/paper/PMC12064817